SUMMIT THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$16.03
-1.05%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-4.0%
3 months
+22.9%
6 months
-0.5%
1 year
-14.0%
Year to date
-8.3%
52-week range
$12.43 – $26.38
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$12.72B
P/E
-14.9
P/B
20.2
P/S
—
Revenue
$0
Net income
-$856.09M
Diluted EPS
-0.01
Gross margin
—
Net margin
—
Return on equity
-168.90%
Total debt
$20.38M
Cash
$419.68M
Free cash flow
-$459.82M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$215.7M | — | — | -$142.03M |
| Mar 31, 2026 | $0 | -$189.42M | — | — | -$122.54M |
| Dec 31, 2025 | $0 | -$219.17M | — | — | -$102.1M |
| Sep 30, 2025 | $0 | -$231.79M | — | — | -$93.15M |
| Jun 30, 2025 | $0 | -$565.71M | — | — | -$66.74M |
| Mar 31, 2025 | $0 | -$62.91M | — | — | -$61.59M |
| Dec 31, 2024 | $0 | -$61.2M | — | — | -$48.69M |
| Sep 30, 2024 | $0 | -$56.25M | — | — | -$30.36M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent SMMT news
All market newsNo ticker-linked stories are in the current archive.